China scuttles Intel’s $5.4bn deal to buy Israeli chipmaker
Intel to pay termination fee of $353m
16 August 2023 - 21:02
byAnirban Sen
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Tower Semiconductor's offices in Migdal HaEmek, northern Israel, February 28 2022. Picture: AMIR COHEN/REUTERS
New York — Intel scrapped its $5.4bn deal to buy Israeli contract chipmaker Tower Semiconductor after their merger agreement expired without regulatory approval from China.
US-listed shares of the Israeli company fell about 11% in premarket trading.
Intel, which had decided to buy Tower last year, will pay a termination fee of $353m to the latter, the company said in a statement.
"After careful consideration and thorough discussions and having received no indications regarding certain required regulatory approval, both parties have agreed to terminate their merger agreement having passed the August 15, 2023 outside date," Tower Semiconductor said in a statement.
The development underscores how tensions between the US and China over issues including trade, intellectual property and the future of Taiwan are spilling over into corporate dealmaking, especially when it comes to technology companies.
Last year, DuPont De Nemours scrapped its $5.2bn deal to buy electronics materials maker Rogers after delays in securing approval from Chinese regulators.
Intel CEO Pat Gelsinger had said he was trying to get the Tower deal approved by Chinese regulators and had visited the country as recently as last month to meet with government officials.
But Gelsinger also said Intel was investing in its foundry business, which makes chips for other companies, irrespective of the Tower deal.
In June, Israeli Prime Minister Benjamin Netanyahu announced that Intel had agreed to spend $25bn on a new factory in Israel, the largest international investment in the country.
Investors had given up hope on the Tower deal as a result. Tower’s Nasdaq-listed shares ended trading at $33.78 on Tuesday, a steep discount to the $53 per share deal price.
In the second quarter, Intel’s foundry business reported revenue of $232m, up from $57m a year earlier, as it made advances on rivals such as industry leader Taiwan Semiconductor Manufacturing.
The rise in foundry sales came from "advanced packaging", a process in which Intel can combine pieces of chips made by another company to create a more powerful chip.
Demand for Intel’s chips has cooled after two years of strong growth driven by remote work during the pandemic, leading the chipmaker to turn to cost cuts. It has committed to trimming $3bn in costs this year, with an aim of saving between $8bn and $10bn by the end of 2025.
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
China scuttles Intel’s $5.4bn deal to buy Israeli chipmaker
Intel to pay termination fee of $353m
New York — Intel scrapped its $5.4bn deal to buy Israeli contract chipmaker Tower Semiconductor after their merger agreement expired without regulatory approval from China.
US-listed shares of the Israeli company fell about 11% in premarket trading.
Intel, which had decided to buy Tower last year, will pay a termination fee of $353m to the latter, the company said in a statement.
"After careful consideration and thorough discussions and having received no indications regarding certain required regulatory approval, both parties have agreed to terminate their merger agreement having passed the August 15, 2023 outside date," Tower Semiconductor said in a statement.
The development underscores how tensions between the US and China over issues including trade, intellectual property and the future of Taiwan are spilling over into corporate dealmaking, especially when it comes to technology companies.
Last year, DuPont De Nemours scrapped its $5.2bn deal to buy electronics materials maker Rogers after delays in securing approval from Chinese regulators.
Intel CEO Pat Gelsinger had said he was trying to get the Tower deal approved by Chinese regulators and had visited the country as recently as last month to meet with government officials.
But Gelsinger also said Intel was investing in its foundry business, which makes chips for other companies, irrespective of the Tower deal.
In June, Israeli Prime Minister Benjamin Netanyahu announced that Intel had agreed to spend $25bn on a new factory in Israel, the largest international investment in the country.
Investors had given up hope on the Tower deal as a result. Tower’s Nasdaq-listed shares ended trading at $33.78 on Tuesday, a steep discount to the $53 per share deal price.
In the second quarter, Intel’s foundry business reported revenue of $232m, up from $57m a year earlier, as it made advances on rivals such as industry leader Taiwan Semiconductor Manufacturing.
The rise in foundry sales came from "advanced packaging", a process in which Intel can combine pieces of chips made by another company to create a more powerful chip.
Demand for Intel’s chips has cooled after two years of strong growth driven by remote work during the pandemic, leading the chipmaker to turn to cost cuts. It has committed to trimming $3bn in costs this year, with an aim of saving between $8bn and $10bn by the end of 2025.
Reuters
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Related Articles
Biden’s ‘Inflation Reduction Act’ reality check
Intel secures €10bn in German state subsidies to build chip plant
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.